Nephrogenic Systemic Fibrosis Risk and Liver Disease

Table 2

NSF and severe renal and severe liver disease. Severe renal disease was found to have a significant association with NSF compared to nonsevere renal disease. Severe liver disease did not have a significant association with NSF compared to nonsevere liver disease. MELD represents the Model for End Stage Liver disease score average.

Characteristics	NSF negative	NSF positive	𝑃 value
Renal disease			0.03
GFR > 30	289	0
GFR 0–29	21	2
Liver disease			0.412
Class A and B (mild/mod.) (MELD avg. 11.7 and 22.5)	241	1
Class C (severe) (MELD avg. 33.7)	69	1